Aging Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea.
Aging (Albany NY). 2020 Nov 16;12(22):23394-23408. doi: 10.18632/aging.103933.
Aging is defined as a time-dependent functional decline that occurs in many physiological systems. This decline is the primary risk factor for prominent human pathologies such as cancer, metabolic disorders, cardiovascular disorders, and neurodegenerative diseases. Aging and age-related diseases have multiple causes. Parabiosis experiments, in which the circulatory systems of young and old mice were surgically joined, revealed that young plasma counteracts aging and rejuvenates organs in old mice, suggesting the existence of rejuvenating factors that become less abundant with aging. Diverse approaches have identified a large number of plasma proteins whose levels differ significantly between young and old mice, as well as numerous rejuvenating factors that reverse aged-related impairments in multiple tissues. These observations suggest that increasing the levels of key rejuvenating factors could promote restorative biological processes or inhibit pathological degeneration. Inspired by such findings, several companies have begun selling "young blood transfusions," and others have tested young plasma as a treatment for Alzheimer's disease. Here, we summarize the current findings regarding rejuvenating factors.
衰老是指在许多生理系统中发生的与时间相关的功能下降。这种下降是癌症、代谢紊乱、心血管疾病和神经退行性疾病等人类主要病理的主要风险因素。衰老和与年龄相关的疾病有多种原因。将年轻和年老小鼠的循环系统通过手术连接起来的并体实验表明,年轻的血浆能抵抗衰老并使年老小鼠的器官恢复活力,这表明存在具有恢复活力的因子,随着衰老其丰度会降低。不同的方法已经确定了大量的血浆蛋白,其在年轻和年老小鼠之间的水平有显著差异,以及许多能逆转多种组织与年龄相关损伤的恢复活力的因子。这些观察结果表明,增加关键恢复活力因子的水平可以促进恢复性的生物过程或抑制病理性退化。受这些发现的启发,几家公司已经开始销售“年轻血液输注”,还有其他公司测试年轻血浆作为治疗阿尔茨海默病的方法。在这里,我们总结了关于恢复活力因子的最新发现。